These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 35799779)

  • 1. The Accuracy of Sequence-Specific Oligonucleotide and Real-Time Polymerase Chain Reaction HLA Typing in Determining the Presence of Pre-Transplant Donor-Specific Anti-HLA Antibodies and Total Eplet Mismatches for Deceased Donor Kidney Transplantation.
    Larkins NG; D'Orsogna L; Taverniti A; Sharma A; Chakera A; Chan D; Krishnan A; Wong G; Lim WH
    Front Immunol; 2022; 13():844438. PubMed ID: 35799779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended genomic HLA typing identifies previously unrecognized mismatches in living kidney transplantation.
    Lehmann C; Pehnke S; Weimann A; Bachmann A; Dittrich K; Petzold F; Fürst D; de Fallois J; Landgraf R; Henschler R; Lindner TH; Halbritter J; Doxiadis I; Popp B; Münch J
    Front Immunol; 2023; 14():1094862. PubMed ID: 36776892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eplet Mismatch Load and
    Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
    J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of assigning 2-field HLA alleles from real-time PCR on deceased donor assessments and conformance with high resolution alleles.
    Hiho S; Bowman S; Hudson F; Sullivan L; Carroll R; Diviney M
    HLA; 2023 Nov; 102(5):570-577. PubMed ID: 37128703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of sequence-specific oligonucleotide probe vs next generation sequencing for HLA-A, B, C, DRB1, DRB3/B4/B5, DQA1, DQB1, DPA1, and DPB1 typing: Toward single-pass high-resolution HLA typing in support of solid organ and hematopoietic cell transplant programs.
    Smith AG; Pereira S; Jaramillo A; Stoll ST; Khan FM; Berka N; Mostafa AA; Pando MJ; Usenko CY; Bettinotti MP; Pyo CW; Nelson WC; Willis A; Askar M; Geraghty DE
    HLA; 2019 Sep; 94(3):296-306. PubMed ID: 31237117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Predicted HLA T-Cell Epitope Targets and T-Cell-Mediated Rejection After Kidney Transplantation.
    Senev A; Van Loon E; Lerut E; Coemans M; Callemeyn J; Daniëls L; Kerkhofs J; Koshy P; Kuypers D; Lamarthée B; Sprangers B; Tinel C; Van Craenenbroeck AH; Van Sandt V; Emonds MP; Naesens M
    Am J Kidney Dis; 2022 Dec; 80(6):718-729.e1. PubMed ID: 35690154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
    Yanyiam P; Kantachuvesiri S; Thammanichanond D
    Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
    Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
    Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
    Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
    Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant loss.
    Sapir-Pichhadze R; Zhang X; Ferradji A; Madbouly A; Tinckam KJ; Gebel HM; Blum D; Marrari M; Kim SJ; Fingerson S; Bashyal P; Cardinal H; Foster BJ
    Kidney Int; 2020 Apr; 97(4):778-785. PubMed ID: 32059998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation and agreement between eplet mismatches calculated using serological, low-intermediate and high resolution molecular human leukocyte antigen typing methods.
    Fidler S; D'Orsogna L; Irish AB; Lewis JR; Wong G; Lim WH
    Oncotarget; 2018 Mar; 9(17):13116-13124. PubMed ID: 29568344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DPB1 and DPA1 ~ DPB1 linkage mismatch affects the survival of recipients receiving HLA-14/14 matched unrelated donor HSCT.
    Liu S; Zhang T; Wu X; Yuan X; Zhu W; Chen L; Jiang X; Yang T; Li Y; Wang L; Gong Y; Wu D; Bao X; He J
    HLA; 2024 Jun; 103(6):e15542. PubMed ID: 38887889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human leukocyte antigen eplet mismatching is associated with increased risk of graft loss and rejection after pediatric heart transplant.
    Albers EL; Friedland-Little JM; Hong BJ; Kemna MS; Warner P; Law YM
    Pediatr Transplant; 2022 Feb; 26(1):e14126. PubMed ID: 34476876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Rare HLA-DRB1*14:22-DQB1*04:01 Haplotype in a Kidney Donor: Implication in the Interpretation of Donor-Specific Antibody in Kidney Transplantation-A Case Report.
    Mongkolsuk T; Tammakorn C; Kitpoka P; Thammanichanond D
    Transplant Proc; 2016 Apr; 48(3):943-5. PubMed ID: 27234774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hlaR: A rapid and reproducible tool to identify eplet mismatches between transplant donors and recipients.
    Johnson AC; Zhang J; Cliff Sullivan H; Wiebe C; Bray R; Gebel H; Larsen CP
    Hum Immunol; 2022 Mar; 83(3):248-255. PubMed ID: 35101308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of T and B Cell Epitopes to Predict the Risk of
    Sakamoto S; Iwasaki K; Tomosugi T; Niemann M; Spierings E; Miwa Y; Horimi K; Takeda A; Goto N; Narumi S; Watarai Y; Kobayashi T
    Front Immunol; 2020; 11():2000. PubMed ID: 32973806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should epitope-based HLA compatibility be used in the kidney allocation system?
    Duquesnoy RJ
    Hum Immunol; 2017 Jan; 78(1):24-29. PubMed ID: 27771385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent typing of over 4000 samples by long-range PCR amplicon-based NGS and rSSO revealed the need to verify NGS typing for HLA allelic dropouts.
    Kong D; Lee N; Dela Cruz ID; Dames C; Maruthamuthu S; Golden T; Rajalingam R
    Hum Immunol; 2021 Aug; 82(8):581-587. PubMed ID: 33980471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between human leukocyte antigen eplet mismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidney transplant recipients.
    Sharma A; Taverniti A; Graf N; Teixeira-Pinto A; Lewis JR; Lim WH; Alexander SI; Durkan A; Craig JC; Wong G
    Pediatr Nephrol; 2020 Jun; 35(6):1061-1068. PubMed ID: 32065279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.